Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;107(3):278-291.
doi: 10.1111/cge.14649. Epub 2024 Dec 12.

Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study

Luise Kessler  1 , Jeremias Krause  1 , Florian Kraft  1 , Asmaa K Amin  2 , Gyorgy Fekete  3 , Anna Lengyel  3 , Eva Pinti  3 , Arpad Kovacs  3 , Annette Lischka  1 , Katja Eggermann  1 , Ingo Kurth  1 , Cordula Knopp  1 , Miriam Elbracht  1 , Matthias Begemann  1 , Thomas Eggermann  1
Affiliations

Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study

Luise Kessler et al. Clin Genet. 2025 Mar.

Abstract

To assess the suitability of genome sequencing (GS) as the second step in the diagnostics of patients with the features of 11p15.5-associated imprinting disorders (ImpDis: Silver-Russell syndrome [SRS], Beckwith-Wiedemann syndrome [BWS]), we performed short-read GS in patients negatively tested for imprinting disturbances. Obtaining a genetic diagnosis for patients with the features of these syndromes is challenging due to the clinical and molecular heterogeneity and overlap, and many patients remain undiagnosed after the currently suggested stepwise diagnostic workup. GS was conducted in 48 patients (SRS features: n = 37 and BWS features: n = 11). The detection rate differed markedly between the ImpDis: although a genetic cause could be identified in 51% of patients referred with SRS features, no pathogenic variants were detected in patients with BWS features. Thus, GS substantially improves the diagnostic yield and broadens the spectrum of overlapping disorders with SRS features. Obtaining a precise molecular diagnosis provides the basis for a personalized clinical management. Our findings support the use of GS as a second-tier diagnostic tool for patients with growth disturbances, as it addresses all currently known variant types and shortens the diagnostic odyssey.

Keywords: Beckwith–Wiedemann syndrome; Silver–Russell syndrome; diagnostic yield; genome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Patients with clinical suspicion of SRS, now molecularly diagnosed by WGS (y: years).
See this image and copyright information in PMC

References

    1. Lionel A. C., Costain G., Monfared N., et al., “Improved Diagnostic Yield Compared With Targeted Gene Sequencing Panels Suggests a Role for Whole‐Genome Sequencing as a First‐Tier Genetic Test,” Genetics in Medicine 20, no. 4 (2018): 435–443. - PMC - PubMed
    1. Finken M. J. J., van der Steen M., Smeets C. C. J., et al., “Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications,” Endocrine Reviews 39, no. 6 (2018): 851–894. - PubMed
    1. Prawitt D. and Eggermann T., “Molecular Mechanisms of Human Overgrowth and Use of Omics in Its Diagnostics: Chances and Challenges,” Frontiers in Genetics 15 (2024): 1382371. - PMC - PubMed
    1. Eggermann T., Monk D., de Nanclares G. P., et al., “Imprinting Disorders,” Nature Reviews. Disease Primers 9, no. 1 (2023): 33. - PubMed
    1. Wakeling E. L., Brioude F., Lokulo‐Sodipe O., et al., “Diagnosis and Management of Silver–Russell Syndrome: First International Consensus Statement,” Nature Reviews Endocrinology 13, no. 2 (2017): 105–124. - PubMed

LinkOut - more resources